Azitra Reports Q3 2025 Results, Raises $2.8mln Through Equity Line of Credit.

miércoles, 12 de noviembre de 2025, 5:05 pm ET1 min de lectura
AZTR--

• Azitra reports Q3 2025 financial results • Dosed first patient in Phase 1/2 trial for ATR-04 program • Presented positive preclinical data for ATR-01 program • Raised $2.8M through equity line of credit with Alumni Capital LP

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios